# A Study of LY3867070 in Healthy Participants

> **NCT07021547** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 196 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3867070
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07021547
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-27
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07021547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07021547, "A Study of LY3867070 in Healthy Participants". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07021547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*